Roche already has one Alzheimer’s candidate in its pipeline targeting tau, but has added a second via a deal with Belgian drugmaker UCB worth up to $2 billion. The Swiss pharma group is paying $ ...
The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...
There’s no better way to waste half an hour than with the best casual games. Whether it’s a pick-up-and-play puzzler, or an idle tycoon tap-a-thon, sometimes an easy time is a good time, and we have ...
Simply sign up to the Fashion myFT Digest -- delivered directly to your inbox. Last summer, I saw Stevie Nicks in concert for the first time. It was magical for many reasons: her anecdotal ...